US Patent Issued to BAHCESEHIR UNIVERSITESI on Aug. 26 for "Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor" (Turkish Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,128, issued on Aug. 26, was assigned to BAHCESEHIR UNIVERSITESI (Istanbul).

"Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor" was invented by Serdar Durdagi (Besiktas/Istanbul, Turkey), Timucin Avsar (Besiktas/Istanbul, Turkey), Muge Didem Orhan (Besiktas/Istanbul, Turkey), Gurbet Cacan (Besiktas/Istanbul, Turkey), Berna Dogan (Besiktas/Istanbul, Turkey) and Seyma Calis (Besiktas/Istanbul, Turkey).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2."

The patent was fi...